Product Description
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Australia | Colombia | Dominican Republic
Approved Indications: None
Known Adverse Events: None
Company: Dr. Tony Cheung
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 4: Cesarean Section|Surgical Wound Infection|Oncology Unspecified
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| AA-2024-3 | N/A |
Not yet recruiting |
Surgical Wound Infection|Cesarean Section|Obesity |
2025-07-31 |
|
| STU 2021-0791 | N/A |
Active, not recruiting |
Injuries/wounds Unspecified |
2024-04-04 |
|
| NCT02459093 | P4 |
Completed |
Cesarean Section|Surgical Wound Infection |
2016-07-01 |
|
| LAP-APR-2012-028 | P4 |
Completed |
Oncology Unspecified |
2013-12-01 |